關於台灣活力生技新藥
台灣活力生技新藥股份有限公司 (Taivital Biopharmaceutical Co. LTD) 是深耕生物科技的生技新藥公司。藉由專利技術「模版重複聚合酶連鎖反應」建構預設標的免疫原。應用於開發生物製劑作為疾病治療與預防；生產高專一性與高親和力抗體用於體外臨床檢驗。QMS工廠並提供契約抗體生產服務，供應符合法規之體外臨床檢驗 (IVD) 用的抗體。
聯絡方式email: taivital@taivital.com.tw。
Taivital Biopharmaceutical Co. LTD is a promising biotechnology company with a QMS plant facility committed to the manufacturing and development of the highest quality of antibodies for in vitro clinical diagnosis and therapeutic vaccine for disease treatment and prevention. Our innovative Linear Array Epitope (LAE) technology distinguishes us from all others in immunogen design. This new technique combines the use of receptor-mediated uptake and an efficient antigen presentation to allow the induction of immune responses to generate antibodies with high affinity and high specificity against any antigen (including self-antigen). State-of-the-art technology combined with years of experience in immunogen design and antibody purification assures that we deliver superior immunogens and antibodies at affordable prices. Additionally, we specialize in a new affinity purification technology that purifies antibodies and offer this service to customers who need a QMS plant facility to prepare IVD antibodies. You can order or request quotes for customer service directly via e-mail at taivital@taivital.com.tw
產品中心
